Regenicin, Inc.
RGIN
Revenue
0.00
0.000.00%
-Assets
11.86M
▲64.87k▲0.5500%
3 Months ChangeLiabilities
3.39M
▼-1.01M▼-22.99%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-09-14
Form 8-K
ID: 0001662252-23-000022
2023-05-15
Form 10-Q
ID: 0001662252-23-000017
2023-02-13
Form 10-Q
ID: 0001662252-23-000012
2022-08-12
Form 10-Q
ID: 0001662252-22-000028
2022-05-23
Form 10-Q
ID: 0001662252-22-000025
2022-02-14
Form 10-Q
ID: 0001662252-22-000011
2021-08-23
Form 10-Q
ID: 0001662252-21-000018
2021-05-17
Form 10-Q
ID: 0001662252-21-000009
2021-02-22
Form 10-Q
ID: 0001662252-21-000007
2020-08-19
Form 10-Q
ID: 0001662252-20-000073